Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Totally agree. With a ridiculous MCAP of around £30m - this should easily be a £100m+ company,
Expecting atleast 4p in the near term, ++ way more as more news comes in
although i believe that significant value can and will be created here - it wont be within the short term.
Opportunities elsewhere merit investment rather than me waiting until next year.
I will be back - (and hopefully the price wont have shifted too much by then)
Seeing some good potential here... with excellent test results from the well, which will provide a material uplift to the groups production and will deliver strong returns with minimal costs.
Mcap of £33m is ridiculous given Ebitda estimate of £10m in 2020 and £16m in 2021.
FinnCap issued a note last week, same day of the RNS, with a target price of 3.x pence. Upside of 140+%
With a caveat stating there would be significant increases in the target price if more positive news keeps flowing.
Can someone find that note?
My guess is that they'll want more cash via a share issue.
Next week... interested to see if they give us some more insight into the progression of the regulatory approvals and timelines and details of any potential partnerships in play.
Good to see an increase in the number of >£10k buys.
The positive note from Trinity is most welcome!
If you look at historic charts for this share then you’ll notice they follow a pattern, next leg is hitting 30p very soo
Agreed - the webinar has kept me on board - lots of positives to be had, and were at the start of an exciting post-covid period.
Hoping for some news in the webinar today...
If not, then opportunities elsewhere in the short term.
"The big money is not in the buying or selling, but in the waiting"
Haha of course, In that case every man should have this in their man bag.
Market potential is huge either way.
On a few fronts:
A) the number of sells I’m seeing
B) the price target of our in house broker seems to be ridiculous
C) the number of options given at the 15p mark.
D) completely lost its momentum
Still holding but only just.
First line of defence meaning you go to a doctor with the ED issue, the first things they’ll likely prescribe/ ask you to try is the gel, as there are virtually no medical side effects.
Just awaiting regulatory approval, and a commercial partner - both big ticket items in their own right but results from Phase 3 testing and pre-submission discussions with the regulatory boards show that FUM definitely have a product that is approvable, marketable as there is a genuine need as a first line of defence in erectile dysfunction arena so in which Liberum think it will take a 15% market share (the company think 50% is achievable)..
So either £300 mill of revenue/ £1bill.
NCYT type share growth all over again. You’ll look back at this in 6 months time either with lots of regret that you sold too early or so much happiness from 10+++ bagging.
Not surprised by the SP movement today and for me it’s definitely a hold for the next 6-9 months. There’s so many good things going for it and a steady positive news stream to come over the course of 2020. 20p will look cheap in a few months time.
Rating given by Liberum - a low target of 55p - 85p depending on patent approval....Giving a Mcap range of c£137m - 210m...
Liberum: FUM have a £300m revenue generating product based on low estimates (FUM believe they have a £1bn generating product) - so Liberum have been super conservative here.
Quick back of a fag packet workings - Assuming £300m Revenue generates £30m EBITDA x (a low multiple for the industry) 12 = £360m valuation
or 146p.
Stong buy if all falls into place.
Good to read the strong interest for marketing rights for Med3000 in the Financial statements. Here we have a potentially £1bn in revenue product on our hands awaiting regulatory approval.
Futura are well positioned to deliver further positive news through 2020, and I can’t wait.
Just thinking of the financial prospects of an approved Med3000 will bring to the company and shareholders is super exciting.
And significantly undervalued: This company has fantastic revenue growth from large global business, its growing profits and cash.
Strong buy IMHO, and I don’t usually give out an opinion on buy/sell